Gilead’s coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance

Gilead Sciences announced Monday the much-anticipated pricing for its coronavirus treatment remdesivir, saying it will cost hospitals $3,120 for a typical U.S. patient with commercial insurance. CNBC